Sandro Alves

Title: Sandro Alves: Innovator in Gene Therapy

Introduction

Sandro Alves is a notable inventor based in Paris, France. He has made significant contributions to the field of gene therapy, particularly in the treatment of neurological disorders. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Sandro Alves holds a patent for an "Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias." This invention relates to a vector designed for use in treating polyglutamine repeat spinocerebellar ataxia, which includes cholesterol 24-hydroxylase encoding nucleic acid. This patent represents a significant advancement in therapeutic approaches for this challenging condition. He has 1 patent to his name.

Career Highlights

Throughout his career, Sandro has worked with prominent organizations such as Brainvectis and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Sandro has collaborated with notable professionals, including Nathalie Cartier-Lacave and Luis Pereira De Almeida. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Sandro Alves is a distinguished inventor whose work in gene therapy has the potential to transform treatment options for patients with neurological disorders. His contributions to the field are invaluable and continue to inspire future innovations.